Caroline R. Richardson, MD
Max and Buena Lichter Research Professor of Family Medicine
Associate Chair of Research
Co-Director, University of Michigan National Clinical Scholars Program
Department of Family Medicine, University of Michigan Medical School, USA
Dr. Richardson is a physical activity and diabetes prevention researcher who emphasizes the importance of using low-cost and scalable approaches to promoting physical activity. She develops and tests behavioral internet-mediated interventions to increase physical activity, decrease weight, and prevent diabetes. Focusing on components of web-based interventions that are interactive and individually tailored, Dr. Richardson builds interventions that are more than just static informational websites. They incorporate objective monitoring of physical activity, individually tailored feedback and motivational messaging, and online social support to motivate and engage users. Automated, gradually incrementing and individually tailored step-count goals are assigned to participants based on program progress as they build up their endurance. Dr. Richardson was the Director of the Veterans Administration Diabetes Quality Improvement Initiative (QUERI) and conducted a multi-site implementation study of the Diabetes Prevention Program for veterans.
Dr. Richardson current serves as Associate Chair for Research Programs in the Department of Family Medicine. She currently serves as a member of the Institute for Health Policy and Innovation's Institute Leadership Team (ILT). In addition, she leads education and scholarship initiatives as Chair of the IHPI education committee and co-director of the IHPI Clinician Scholars Program (NCSP).
Join the Editorial Board
Susan Alexander, DNP, ANP-BC, ADM-BC
Clinical Associate Professor, University of Alabama in Huntsville College of Nursing, USA
Dr. Alexander is dually certified as an Adult Nurse Practitioner, and in Advanced Diabetes Management, with more than ten years of expertise in caring for patients with diabetes and other chronic conditions. Her present area of interest concerns how informatics tools, particularly mHealth, can be used to improve long-term management for patients with diabetes and other lifelong diseases.
Riccardo Bellazzi, MD, PhD
Professor at the Department of Computer Science and Systems, University of Pavia, Italy
Dr. Bellazzi is currently the chair of the Centre for Health Technologies of the University of Pavia. He is leading the Biomedical Informatics Labs "Mario Stefanelli" and the Laboratory for Biomedical Informatics of the IRCCS Fondazione S. Maugeri. His current research interests are related to biomedical data mining and information systems to support biomedical research.
Tanushree Bose, PhD, MBA
Clinical Development Consultant, Digital Health, San Francisco, USA
Dr. Bose has led clinical development for digital health and personalized nutrition companies. She has a background in pharmacy, genetics, nutrition and digital health.
Perry Gee, PhD, RN
Nurse Scientist, Dignity Health, University of Utah, USA
Dr. Gee is a clinical informatics specialist specializing in research related to consumer health informatics, eHealth, technology-enabled chronic illness self-management and social media for patient engagement.
Jörg Huber, PhD, MSc, DiplPsych
Professor of Health Sciences, University of Brighton, UK
Dr. Huber's applied research in diabetes focuses on biopsychosocial issues, behaviour change, mental health and resilience in people living with diabetes, both young and old (type 1 and 2, monogenetic diabetes).
Sheyu Li, MD
Associate Professor, West China Hospital, Sichuan University, China
Dr. Li's research interests include mobile health care of diabetes and obesity, especially the quality, effectiveness and safety assessment of diabetes apps.
Kara Mizokami-Stout, MD
Clinical Instructor, Endocrinology, Department of Endocrinology, University of Michigan, USA
Dr. Mizokami-Stout is an adult endocrinologist interested in the impact of psychosocial factors on diabetes self-management in the context of advanced chronic microvascular complications as well as diabetes devices including insulin pumps, continuous glucose monitors, and artificial pancreas systems.
Charlene Quinn, RN, PhD, FAAN
Associate Professor, University of Maryland School of Medicine, USA
Dr. Quinn is known for her experience developing and implementing the first large cluster RCT evaluation of a mobile diabetes intervention. She has led or co-led five mobile health (mhealth) and three telehealth research projects, from proof of concept to Phase I clinical studies, including ongoing projects. In these studies, she applied her research experience in gerontology, epidemiology, clinical trials, qualitative methods, and health services utilization and cost analyses. Her clinical expertise in geriatrics, chronic diseases, depression, dementia and palliative care contributes to the translation of her research to primary care, specialty care, nursing homes and senior adult housing.
Leo Quinlan, BSc, PhD
Lecturer, Physiology, School of Medicine NUI Galway, Ireland
Dr. Quinlan has a BSc in Biochemistry and PhD in Stem Cell biology. He is a lecturer in Physiology at NUI Galway since 1999 and a funded investigator at CÚRAM centre for medical device research. His research interests focus on the interface of human physiology and medical device development, with a particular emphasis on electrophysiology and neuromodulation.
Dina Griauzde, MD, MSc
Department of Internal Medicine, University of Michigan, USA
Dr. Griauzde is a primary care physician at the Ann Arbor VA and a health services researcher in the Department of Internal Medicine at the University of Michigan. Her work focuses on developing and testing novel, patient-centered strategies for type 2 diabetes prevention in primary care settings.